Cancer Second Opinion in India for Patients from Mauritius

Can patients from Mauritius get a cancer second opinion in India?

Yes. Patients from Mauritius can obtain a cancer second opinion in India through a structured oncology review that includes pathology re-evaluation, imaging interpretation, and a multidisciplinary tumour board assessment. Lilavati International in Mumbai provides oncology second opinion services to international patients, including those travelling from Mauritius, with dedicated international patient-care support.

Lilavati International is located at A-791, Bandra Reclamation Road, Bandra West, Mumbai – 400050, and holds Joint Commission International (JCI) accreditation and NABH Hospital Accreditation, providing an internationally recognised standard of clinical care for patients arriving from Mauritius and other countries.

When should a patient from Mauritius seek a cancer second opinion in India?

Seeking a second opinion is appropriate in several specific clinical situations. Patients from Mauritius should consider an oncology second opinion in India if any of the following apply:

• A cancer diagnosis has been received but the recommended treatment — surgery, chemotherapy, or radiotherapy — feels unclear or insufficiently explained.
• The cancer type is rare, complex, or the local pathology report is inconclusive.
• The proposed treatment plan involves major surgery, organ removal, or high-dose chemotherapy and the patient wants independent confirmation.
• A first treatment has not produced the expected response and the oncologist is recommending a change in protocol.
• The patient has received conflicting opinions from two local specialists.
• A cancer has recurred after initial treatment and a new management plan is being proposed.
• The patient is considering clinical trials or newer targeted therapies not available locally in Mauritius.

What reports do I need for a cancer second opinion in India?

Bringing a complete set of medical records allows the oncology team at Lilavati International to conduct a thorough review without repeating avoidable investigations. The following documents are typically required:

Documents in languages other than English should be accompanied by a certified translation. The international patient-care team at Lilavati International can advise on document submission prior to travel.

How does a cancer second opinion work at a Mumbai hospital?

The second opinion process at Lilavati International in Mumbai follows a structured pathway designed for international patients from Mauritius and other countries:

1. Pre-arrival document submission — Share your medical records digitally with the international patient-care team before travelling. This allows the oncology team to review your case and schedule the appropriate specialists in advance.
2. Pathology review — Biopsy slides or blocks are re-examined by the hospital's pathology department to confirm or re-characterise the diagnosis.
3. Imaging review — Existing scans are reviewed. Where additional imaging is required, Lilavati International provides round-the-clock access to CT, MRI, ultrasound, and a full diagnostic laboratory, including PET-CT scanning.
4. Oncology consultation — A specialist oncology consultation is conducted to discuss findings directly with the patient and accompanying family members.
5. Tumour board review — Complex cases are presented at a multidisciplinary tumour board, where oncologists, surgeons, radiologists, and pathologists review the case together and reach a consensus recommendation.
6. Written opinion report — A detailed written second opinion report is provided, summarising the reviewed diagnosis, the board's findings, and the recommended treatment approach. This report can be shared with the patient's treating team in Mauritius.

Will a second opinion change my cancer treatment plan?

A second opinion does not always result in a different treatment plan, but it frequently provides additional clarity or refinement. Outcomes of an oncology second opinion can include:

• Confirmation — The original diagnosis and treatment plan are validated, giving the patient confidence to proceed.
• Refinement — The cancer subtype, stage, or biomarker profile is clarified, leading to a more precisely targeted treatment protocol.
• Change in approach — A different surgical technique, drug combination, or sequencing of therapies is recommended based on the reviewing team's assessment.
• Access to newer options — The reviewing oncologist may identify eligibility for targeted therapy, immunotherapy, or clinical trials not previously considered.
• Pathology correction — In some cases, re-examination of biopsy material identifies a different cancer type, which materially changes the treatment pathway.

The written report from Lilavati International's oncology team is structured so that it can be shared directly with the patient's treating oncologist in Mauritius to facilitate a collaborative decision.

How does Lilavati International support cancer second opinion for patients from Mauritius?

Lilavati International in Mumbai is a quaternary-care multi-specialty hospital with specialist support across oncology and related disciplines, including interventional radiology and cardiothoracic surgery. The hospital's infrastructure supports a comprehensive oncology review under one roof:

• Round-the-clock access to CT, MRI, ultrasound, and a full diagnostic laboratory
• PET-CT scanning for staging and treatment response assessment
• On-site pathology department for biopsy slide and block review
• Multidisciplinary tumour board capability drawing on specialists across relevant disciplines
• Dedicated international patient-care support for patients travelling from Mauritius
• Blood bank, endoscopy, and advanced critical-care units (ICU, ICCU, SICU) available if inpatient care is required following the review

The hospital holds JCI accreditation (8th Edition), NABH Hospital Accreditation, and NABL Accreditation for its laboratory services — internationally recognised standards relevant to patients seeking a credible independent review of their cancer diagnosis.

To discuss your case before travelling, contact the international patient-care team using the details below. No appointment is required for emergency care; for planned second opinion consultations, advance coordination is recommended.